Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced an agreement with Germany's Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to implement the use of whole-genome sequencing (WGS) in critically ill children suspected of having a genetic or rare disease.
Two years into the pandemic that has killed millions and shaken the global economy, the world still lacks a unified effort to detect and fight future outbreaks using genetic tools, said Illumina Inc. Chief Executive Officer Francis deSouza.
A new study from the National Institute on Alcohol Abuse and Alcoholism shows alcohol-related deaths increased by 25% in 2020 and remained elevated in 2021.
Minority Health Month fact: Lesbian, gay, bisexual, and transgender adults are more likely to experience a mental health condition than cisgender, heterosexual adults.
The International WELL Building Institute (IWBI) today announced the launch of its inaugural WELL City Advisory, which will explore ways to support local governments worldwide in demonstrating leadership on advancing health and well-being across their buildings, organizations and communities.
If left untreated, VL kills 95% of its victims. Though progress has been made, we still have a way to go and, as we look to the next decade, eliminating VL will continue to be a priority for Gilead Sciences.
SC Johnson Chairman and CEO Fisk Johnson welcomed Her Excellency Samia Suluhu Hassan, President of the United Republic of Tanzania, to Racine to discuss their shared commitment to eradicating malaria.
The SCS Kingfisher certification mark is showing up on an increasing number of products around the world. It differentiates companies that are making...
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
